Correction to Codelivery of Natural Compounds With a Dual-Targeted Nanoparticle Delivery System for Improving Synergistic Therapy in an Orthotopic Tumor Model

ACS Applied Materials & Interfaces - United States
doi 10.1021/acsami.0c05903
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Nanoparticle a Targeted Drug Delivery System: An Overview

International Research Journal of Pharmacy
2019English

Liposomal Codelivery of an SN38 Prodrug and a Survivin siRNA for Tumor Therapy

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2018English

Targeted Delivery for Breast Cancer Therapy: The History of Nanoparticle-Albumin-Bound Paclitaxel

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2010English

A Dual Tracer 18f-FCH/18f-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft Model

PLoS ONE
Multidisciplinary
2016English

Preparation of Quantum Dot/Drug Nanoparticle Formulations for Traceable Targeted Delivery and Therapy

Theranostics
MedicineToxicologyPharmaceuticsPharmacology
2012English

Retraction of “Dual-Responsive Polymer Coated Superparamagnetic Nanoparticle for Targeted Drug Delivery and Hyperthermia Treatment”

ACS Applied Materials & Interfaces
MedicineMaterials ScienceNanotechnologyNanoscience
2018English

Continuous Local Delivery of Interferon-Β Stabilizes Tumor Vasculature in an Orthotopic Glioblastoma Xenograft Resection Model

Surgery
Surgery
2011English

Tumor-Targeted Drug Delivery With Aptamers

Current Medicinal Chemistry
Organic ChemistryBiochemistryDrug DiscoveryMolecular MedicinePharmacology
2011English

Folic Acid Receptor-Targeted Human Serum Albumin Nanoparticle Formulation of Cabazitaxel for Tumor Therapy

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy